Nanoparticulate quinazoline derivative formulations

Details for Australian Patent Application No. 2006235487 (hide)

Owner Elan Pharma International Limited

Inventors Liversidge, Gary; Jenkins, Scott

Agent Davies Collison Cave

Pub. Number AU-B-2006235487

PCT Pub. Number WO2006/110811

Priority 60/670,429 12.04.05 US

Filing date 12 April 2006

Wipo publication date 19 October 2006

Acceptance publication date 22 December 2011

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Event Publications

22 November 2007 PCT application entered the National Phase

  PCT publication WO2006/110811 Priority application(s): WO2006/110811

22 December 2011 Application Accepted

  Published as AU-B-2006235487

19 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006235489-Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases

2006235486-Polymorphs of 3-o-(3',3'-dimethylsuccinyl) betulinic acid di-N-methyl-D-glucamine